UBS Group AG - REVIVA PHARMACEUTCLS HLDGS I ownership

REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 15 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of REVIVA PHARMACEUTCLS HLDGS I
ValueSharesWeighting
Q4 2021$6,0000.0%1,964
+24.5%
0.00%
Q3 2021$6,000
-40.0%
1,578
-22.4%
0.00%
Q2 2021$10,000
-33.3%
2,033
+18.9%
0.00%
Q4 2020$15,0001,7100.00%
Other shareholders
REVIVA PHARMACEUTCLS HLDGS I shareholders Q4 2021
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 564,000$2,752,3200.84%
EMC Capital Management 123,915$6130.45%
Ikarian Capital, LLC 5,095$2,486,3600.30%
SABBY MANAGEMENT, LLC 44,593$217,6140.16%
ARMISTICE CAPITAL, LLC 600,000$2,928,0000.04%
GSA CAPITAL PARTNERS LLP 70,181$3420.03%
Caption Management, LLC 275,200$1,342,9760.02%
Caption Management, LLC 216,600$1,057,0080.02%
BOOTHBAY FUND MANAGEMENT, LLC 109,700$535,3360.01%
J. Goldman & Co LP 75,000$366,0000.01%
View complete list of REVIVA PHARMACEUTCLS HLDGS I shareholders